Half-life of maternal labetalol in a premature infant

A. Haraldsson*, W. Geven

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Intra-uterine heart arrhythmia, postpartal respiratory insufficiency, bradycardia and hypoglycaemia were observed in a premature infant (37 weeks gestational age) delivered by a caesarian section. The mother had been treated with adequate doses of labetalol because of pregnancy-induced hypertension and her plasma concentration was found to be 89 μg/1 one day after delivery. The half-life of labetalol in the plasma of the infant was found to be approximately 24 h, i.e. substantially longer than in normal adults. The half-life of labetalol in newborn premature infants may be prolonged as compared to normal adults. More studies are required regarding the pharmacokinetics of this agent in premature infants and newborn babies.

Original languageEnglish
Pages (from-to)229-231
Number of pages3
JournalPharmaceutisch Weekblad Scientific Edition
Volume11
Issue number6
DOIs
Publication statusPublished - Dec 1989

Other keywords

  • Half-life
  • Infant, premature
  • Labetalol
  • Pharmacokinetics

Fingerprint

Dive into the research topics of 'Half-life of maternal labetalol in a premature infant'. Together they form a unique fingerprint.

Cite this